Re: Long-term Quality of Life of Testicular Cancer Survivors Differs According to Applied Adjuvant Treatment and Tumour Type
Eur Urol
.
2024 Dec;86(6):591-592.
doi: 10.1016/j.eururo.2024.07.025.
Epub 2024 Aug 10.
Authors
Richard S Matulewicz
1
,
Nirmish Singla
2
,
Kshitij Pandit
3
,
Frederick Millard
3
,
Aditya Bagrodia
4
Affiliations
1
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
2
John Hopkins Medical Center, Baltimore, MD, USA.
3
University of California-San Diego, La Jolla, CA, USA.
4
University of California-San Diego, La Jolla, CA, USA. Electronic address: bagrodia@health.uscd.edu.
PMID:
39129107
DOI:
10.1016/j.eururo.2024.07.025
No abstract available